Deans, Zandra C. http://orcid.org/0000-0001-9361-6012
Butler, Rachel
Cheetham, Melanie
Dequeker, Elisabeth M. C.
Fairley, Jennifer A.
Fenizia, Francesca
Hall, Jacqueline A.
Keppens, Cleo
Normanno, Nicola
Schuuring, Ed
Patton, Simon J.
Funding for this research was provided by:
University of Edinburgh
Article History
Received: 21 June 2018
Revised: 8 February 2019
Accepted: 2 April 2019
First Online: 26 April 2019
Compliance with ethical standards
:
: The authors declare the following conflict of interest:Schuuring E performed lectures for Illumina, Novartis, Pfizer, BioCartis; is consultant in advisory boards for AstraZeneca, Pfizer, Novartis, BioCartis; and received financial support from Roche, Biocartis, BMS, Pfizer (all fees to the Institution).Deans ZC is consultant in advisory boards for AstraZeneca and Roche.Butler R is a consultant in advisory boards for AstraZeneca, Novartis, Roche, Pfizer, Bristol-Myers Squibb.All authors contributed equally to the design and delivery of the workshop, and preparation of the manuscript.
: The authors comply with the Ethical Standards.